PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Mar-2023 NTP Announces New Board Members & Executive Chairman to Spearhead Further Company Development and Internationalization B3C newswire
14-Mar-2023 Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit Sernova Corp.
14-Mar-2023 DEFENCE THERAPEUTICS SIGNS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER Defence Therapeutics Inc.
14-Mar-2023 Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray Marinomed Biotech AG
14-Mar-2023 Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time Dermapharm Holding SE
14-Mar-2023 Biotest AG: Biotest donates human albumin for earthquake victims in Turkey Biotest AG
14-Mar-2023 PolyPeptide reports weaker performance in 2022 – expects growth to recover in the second half of 2023 PolyPeptide
14-Mar-2023 Straumann Group launches digital solutions for dentistry at International Dental Show (IDS) in Cologne Straumann Holding AG
14-Mar-2023 Newron announces 2022 financial results and provides outlook for 2023 Newron Pharmaceuticals S.p.A.
14-Mar-2023 Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth Medartis Holding AG
13-Mar-2023 SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share SYNLAB AG
13-Mar-2023 Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution ABIVAX
10-Mar-2023 Richard Stedman rejoins ACG as the CEO of Engineering Division ACG
09-Mar-2023 Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023 MorphoSys AG
09-Mar-2023 STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023 STRATEC SE
09-Mar-2023 Antev Receives US FDA Guidance on Teverelix® Phase 3 Trial Design for Treating Advanced Prostate Cancer Patients with Increased Cardiovascular Risk Antev Ltd
09-Mar-2023 Cancer Research UK Signs Multi-Project Collaboration With UCB To Advance Oncology Antibody Candidates UCB
09-Mar-2023 Merck’s MK-0616 holds potential to become first oral PCSK9 inhibitor in dyslipidemia market, says GlobalData GlobalData
09-Mar-2023 IIVS will offer ToxTracker®, expanding its portfolio of animal-free genetic toxicology assays Institute for In Vitro Sciences (IIVS)
09-Mar-2023 Labels with temperature and light indicators for easy and safe use Faller Packaging